BLT 0.00% 2.6¢ benitec biopharma limited

Benitec quiet period to end Sept. 28, page-14

  1. 179 Posts.
    For the share price to find support the company needs to have a concerted marketing drive now and not after results are released, Bloomberg, Bioshares, Alan Kohler, Finance News, Sky News, CNBC and on and on.

    The share price being this low is the result of an 'IPO at any cost' followed by a vacuum of news flow compounding the problem, prior to any announcement to get the most bang for buck you have to make everyone aware of your relevance then hit them between the eyes with the results (which we expect to be positive) of the TT-034 trial. Without a reason to support the share price it will continue to grind lower.

    The squeaky wheel gets the oil.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.